<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge"/>
        <script src='echarts.min-4.8.0.js'></script>
        <script src='echarts-wordcloud.min.js'></script>
    </head>
    <body>
        <style>
            html, body, #main {
                width: 100%;
                height: 100%;
                margin: 0;
            }
        </style>
        <div id='main'></div>
        <script>
            var chart = echarts.init(document.getElementById('main'));
            var keywords = {"ETV1":1,
"Triple-negative breast cancer":1,
"miR-17-5p":1,
"Korea":2,
"body mass index":1,
"cancer survivor":1,
"female":1,
"obesity":1,
"second primary cancer":1,
"Thyroid":14,
"branchial cleft cyst":1,
"cystic neck lesion":1,
"papillary thyroid carcinoma":23,
"Bilateral axillo-breast approach":1,
"Robotic lateral cervical lymph node dissection":1,
"Robotic thyroidectomy":1,
"EPIC":1,
"cohort":1,
"flavonoids":1,
"intake":1,
"polyphenols":1,
"thyroid cancer":15,
"Dysphagia":1,
"Head and neck cancer":1,
"Radiation treatment":1,
"Service delivery":1,
"Speech pathology":1,
"Toxicity":1,
"Sinonasal cancer":1,
"induction chemotherapy":1,
"multimodal treatment":1,
"radiation":1,
"surgery":3,
"CT":1,
"adult patient-specific":1,
"effective dose":1,
"organ dose":1,
"size-specific dose estimate":1,
"Breast neoplasms":3,
"Cancer survivors":1,
"Pregnancy":1,
"177Lu-PP-F11N":1,
"cholecystokinin 2 receptor targeting":1,
"peptide receptor radionuclide therapy":1,
"theranostics":1,
"Bleeding":1,
"Invasive disease":1,
"Kinase inhibitors":1,
"Apoptosis":3,
"Poorly differentiated thyroid carcinoma":1,
"Proliferation":2,
"Radioiodine uptake":1,
"Sodium–iodide symporter":1,
"microRNA-875-5p":1,
"cervical lymph node":1,
"lobectomy":2,
"recurrence":5,
"CUP":1,
"Cancer of unknown primary":1,
"MUO":1,
"direct general practitioner referral":1,
"early cancer diagnosis":1,
"metastatic cancer of unidentified origin":1,
"Hyperthyroidism":2,
"Minimally invasive treatments":1,
"Radiofrequency":1,
"Thyroid nodule":5,
"Graves’ disease":1,
"Graves’ orbitopathy":1,
"Idiopathic orbital inflammation":1,
"Orbital lymphoma":1,
"Pseudotumor":1,
"NSQIP":1,
"malignancy":3,
"outcomes":1,
"pediatric":2,
"thyroidectomy":2,
"dysphonia":1,
"laryngeal reinnervation":1,
"thyrohyoid":1,
"vocal fold paralysis":1,
"Ablation":1,
"Differentiated thyroid cancer":4,
"RAI":1,
"Staging":1,
"Predictive gene":1,
"RNA sequencing":1,
"hobnail variant":1,
"central compartment neck dissection":1,
"safety":1,
"transoral endoscopy":1,
"Base of the tongue cancer":1,
"Extended base of the tongue resection":1,
"Flap reconstruction":1,
"Larynx preservation":1,
"Postoperative swallowing function":1,
"Hispanics":1,
"health care disparities":1,
"mortality":2,
"quality of life":1,
"NIFTP":3,
"cytology":2,
"risk of malignancy":2,
"ultrasound":4,
"Congo red":1,
"Hashimoto's thyroiditis":1,
"flow cytometry":1,
"lymphoma":2,
"medullary thyroid carcinoma":4,
"FNA":3,
"TBSRTC":1,
"resection rate":1,
"LDOC1":1,
"NF-κB":1,
"malignant phenotype":1,
"xenograft":1,
"Distant metastases":2,
"External-beam radiotherapy":1,
"Locoregional failure":1,
"Radioactive iodine therapy":1,
"Radiotherapy":4,
"fine needle biopsy":1,
"follicular adenocarcinoma":1,
"ultrasonography":1,
"BRAF":2,
"NRAS":1,
"Idylla":1,
"molecular cytopathology":1,
"differentiated thyroid carcinoma (DTC)":1,
"fine needle lymph node aspiration for thyroglobulin (LN-FNA-Tg)":1,
"follicular thyroid carcinoma (FTC)":2,
"lymph node metastasis (LNM)":1,
"papillary thyroid carcinoma (PTC)":4,
"childhood":1,
"extent of thyroidectomy":1,
"risk stratification":1,
"MEN syndrome":1,
"RET":1,
"children":3,
"Pathologic size":1,
"Thyroid nodules":1,
"Ultrasound imaging":1,
"MICA":1,
"NKG2D":1,
"miRNA":2,
"C228T":2,
"C250T":2,
"SNP":1,
"TERT promoter":3,
"point mutation":2,
"rs2853669":2,
"follicular thyroid adenoma":1,
"follicular thyroid carcinoma":2,
"follicular thyroid neoplasms":1,
"single-nucleotide polymorphism":1,
"PTC":1,
"ceRNA":1,
"circFOXM1":1,
"circRNAs":1,
"target":1,
"CK20":1,
"Merkel cell carcinoma":1,
"oral mucosa":1,
"review":2,
"computer-aided diagnosis":1,
"quantitative image analysis":1,
"Carcinoma":3,
"Contrast-enhanced ultrasound (CEUS)":1,
"Meta-analysis":5,
"Nodule":2,
"Bone resorption":1,
"Osteoclasts":1,
"PP121":1,
"RANKL":1,
"Src":1,
"Breast":1,
"Malignant phyllodes tumors":1,
"Outcome":3,
"RAS mutations":1,
"decision making":1,
"diagnosis":2,
"molecular marker":1,
"thyroid biopsy":1,
"familial":1,
"papillary thyroid cancer":6,
"sporadic":1,
"Bethesda System for Reporting Thyroid Cytopathology":1,
"machine learning":2,
"malignancy prediction":1,
"neural network":1,
"thyroid fine-needle aspiration (FNA)":1,
"fine-needle aspiration (FNA)":1,
"lung mass or nodule":1,
"pulmonary neoplasm":1,
"sclerosing hemangioma":1,
"sclerosing pneumocytoma":1,
"Nuclear medicine":1,
"Occupational exposure":1,
"PET/CT examination":1,
"Radiation induced risk":1,
"Radiopharmaceuticals":1,
"Familial adenomatous polyposis":2,
"Fecal incontinence":1,
"Follow-up":1,
"Survey":1,
"2-Deoxy-D-glucose":1,
"Esophageal cancer":1,
"Photodynamic therapy":1,
"Pyruvate kinase M2":1,
"Warburg effect":1,
"COPZ1":1,
"Immunogenic cell death":1,
"Inflammation":2,
"Type I IFN":1,
"local neoplasm recurrence":1,
"lymph node dissection":1,
"risk factors":1,
"LINC00520":1,
"microRNA-577":1,
"sphingosine kinase 2":1,
"Cancer":4,
"Epidemiology":4,
"Hirschsprung disease":1,
"RCTs":1,
"VEGFR-TKIs":1,
"cancer patients":1,
"proteinuria":1,
"PD-L1":2,
"lymphocytic thyroiditis":1,
"programmed cell death ligand 1":1,
"tumour microenvironment":1,
"Fine-needle aspiration cytology":1,
"Follicular variant of papillary thyroid carcinoma":1,
"TI-RADS":1,
"Thyroid ultrasound":1,
"Adolescents":2,
"Head":1,
"Malignancies":1,
"Neck":2,
"Pediatrics":1,
"Contrast-enhanced ultrasound":1,
"Microvessel density":1,
"Superb microvascular imaging":1,
"adjuvant":1,
"postoperative":1,
"CCAAT enhancer binding protein delta":1,
"Tumor microenvironment":1,
"miR-324-5p":1,
"progression":2,
"ARV-825":1,
"BRD4":1,
"c-Myc":1,
"proteolysis targeting chimera":1,
"thyroid carcinoma":7,
"2020":1,
"Forecasting":1,
"Incidence":1,
"Neoplasms":1,
"Cancer héréditaire":1,
"Carcinome thyroïdien familial":1,
"Cowden syndrome":1,
"DICER1 syndrome":1,
"Familial thyroid carcinoma":1,
"Hereditary cancer":1,
"Polypose adénomateuse familial":1,
"Syndrome DICER1":1,
"Syndrome de Cowden":1,
"Fine-needle aspiration":2,
"INSM-1":1,
"Immunohistochemistry":2,
"Insulinoma-associated protein 1":1,
"cisplatin":1,
"growth-arrest-specific transcript 5":1,
"hepatocellular carcinoma":3,
"miR-222":1,
"CDK6":1,
"influence":1,
"miR-298":1,
"SLC25A1":1,
"long non-coding RNA BRM":1,
"micoRNA-331-3p":1,
"AKT/AMPK/mTOR pathway":1,
"LHPP":1,
"autophagy":1,
"Metastatic spinal cord compression":1,
"Prognosis":8,
"Survival":2,
"Visceral metastasis":1,
"TFF-1":1,
"TTF-1":1,
"lung adenocarcinoma":1,
"mucinous adenocarcinoma":1,
"non-TRU type":1,
"metachronous":1,
"synchronous":1,
"triple primary malignant tumors":1,
"BRAF inhibitor":1,
"CTLA-4":1,
"MAPK targeted therapy":1,
"MEK inhibitor":1,
"PD-1":1,
"combination therapy":1,
"immune checkpoint inhibitor":1,
"Metastasis":4,
"Multinodular goiter":1,
"bone mass density":1,
"osteoporosis":1,
"subclinical hyperthyroidism":1,
"subclinical hypothyroidism":1,
"thyroid dysfunctions":1,
"Breast cancer":4,
"Lung cancer":1,
"Metachronous second primary malignancy":1,
"Oncology":1,
"SEER":1,
"blood plasma":1,
"filter membrane":1,
"silver nanoparticles":1,
"surface-enhanced Raman spectroscopy":1,
"thyroid tumor":2,
"Age of onset":1,
"Development trend":1,
"Pathology, clinical":1,
"Thyroid neoplasms":5,
"Bisphenol A":1,
"bisphenols":1,
"endocrine disruptors":1,
"thyroid hormones":1,
"Biomarkers":1,
"DNA Methylation":1,
"Robust rank aggregation":1,
"Weighted gene co-expression network analysis":1,
"Diffusion magnetic resonance imaging":1,
"Neoplasm staging":1,
"case report":4,
"hypoparathyroidism":3,
"lymph node metastasis":3,
"nanocarbon suspension":1,
"tracheal cavity":1,
"Hashimoto’s thyroiditis":1,
"Regulatory T cells":1,
"autoimmune disease":1,
"interleukin-10":1,
"Pancreas":1,
"Pancreaticoduodenectomy":1,
"cardiac arrhythmias":1,
"thyroid diseases":1,
"thyroid hormone signaling":1,
"kinase":1,
"targeted therapy":2,
"tyrosine kinase inhibitor":1,
"brachiocephalic trunk":1,
"central-compartment lymph node dissection":1,
"lateral-compartment lymph node dissection":1,
"number of metastatic lymph nodes":1,
"right carotid sheath space":1,
"thoracic inlet":1,
"CBF1":1,
"ID4":1,
"MRP1":1,
"chemotherapy resistance":1,
"triple negative breast cancer":1,
"Active surveillance":1,
"Adverse events":1,
"Low-risk papillary thyroid carcinoma":1,
"Vocal cord paralysis":1,
"AIP":1,
"Acromegaly":1,
"Pituitary tumors":1,
"Colon cancer":1,
"Gastrointestinal reaction":1,
"Hyperthermic intraperitoneal chemotherapy":1,
"Warming needling technique":1,
"ATC":1,
"Hypoxia":1,
"NEAT1":1,
"miR-206":1,
"miR-599":1,
"differential expressed circRNAs":1,
"hsa_circ_0007694":1,
"therapeutic target":1,
"androgen receptor":1,
"epithelial-mesenchymal transition":1,
"sex difference":1,
"tumorigenesis":2,
"18F-fludeoxyglucose positron emission tomography-computed tomography":1,
"ovarian carcinoma":1,
"papillary thyroid microcarcinoma":2,
"supraclavicular metastasis":1,
"Hypopharyngeal carcinoma":1,
"Microvascular flap":1,
"Pharyngectomy":1,
"Recurrent cancer":1,
"Salvage surgery":1,
"Autoimmune hepatitis":1,
"Liver":1,
"Reactive lymphoid hyperplasia":1,
"KIF2A":1,
"circEIF3I":1,
"circular RNA":1,
"miR-149":1,
"fusion gene":1,
"hyalinizing trabecular tumor":1,
"sonic hedgehog pathway":1,
"131 I therapy":1,
"recurrence risk":1,
"thyroglobulin":2,
"Differentiated thyroid carcinoma":3,
"Radioiodine":1,
"Remnant ablation":1,
"125I seed implantation":1,
"anaplastic thyroid cancer":1,
"apatinib":2,
"brachytherapy":1,
"multimodal therapy":1,
"Integrin alphaV":1,
"Receptors, CXCR4":1,
"Breast cancer (BC)":1,
"bioinformatics analysis":1,
"tumor mutation burden (TMB)":1,
"Partially cystic nodule":1,
"elastography":1,
"Early-stage":1,
"Population-based":1,
"Registry":1,
"Relative survival":1,
"FLT3 R387Q":1,
"L790F":1,
"REarranged during Transfection":1,
"gene variants":1,
"multiple endocrine neoplasia type 2":1,
"variability":1,
"lymph node dissections":1,
"lymphatic metastasis":1,
"nomogram":2,
"Cold knife":1,
"harmonic scalpel (HS)":1,
"knot tying":1,
"total thyroidectomy (TT)":1,
"4K ultra-high definition camera":1,
"endoscopy":1,
"high definition camera":1,
"transoral thyroidectomy":1,
"MR spectroscopy (MRS)":1,
"differential diagnosis":1,
"diffusion-weighted imaging (DWI)":1,
"magnetic resonance imaging (MRI)":1,
"plasma cell mastitis (PCM)":1,
"Hemithyroidectomy":1,
"prophylactic central neck dissection (CND)":1,
"angiogenesis":1,
"nasopharyngeal carcinoma":1,
"partial oxygen pressure":1,
"BRAF mutation":1,
"GADD45B":1,
"TERT promoter mutation":1,
"prognostic markers":1,
"transcription profiling":1,
"Algorithmic approach":1,
"Hürthle cell carcinoma":1,
"Hürthle cell neoplasm":1,
"Molecular advances":1,
"Oncocyte":1,
"UBAP2":1,
"hsa_circ_0003141":1,
"microRNA-1827":1,
"Checkpoint inhibitor therapy":1,
"Programmed death-ligand 1":1,
"Systematic review":2,
"NanoString":1,
"follicular neoplasms":1,
"gene expression profiling":1,
"Adenocarcinoma of lung":1,
"Neoplasm metastasis":1,
"Longer-term":1,
"Radioactive iodine ablation":1,
"Hypothyroidism":1,
"goitre":1,
"physiology":1,
"Iodine‐131 whole‐body scintigraphy (WBS)":1,
"endoscopic thyroidectomy":1,
"positron emission tomography/computed tomography (PET/CT)":1,
"robot‐assisted thyroidectomy":1,
"single‐photon emission computed tomography/computed tomography (SPECT/CT)":1,
"unusual patterns":1,
"exosome":1,
"galectin-3":1,
"urine":1,
"indeterminate":1,
"malignant":1,
"multinucleated giant cells":1,
"Adenocarcinoma":1,
"Biopsy":1,
"Fine needle":1,
"Follicular":1,
"Humans":1,
"Papillary":1,
"Primary health care":1,
"Referral and consultation":1,
"Cell":1,
"Non Hodgkin's lymphoma":1,
"lymphomas":1,
"Conformity index":1,
"critical organ scoring index":1,
"normal tissue complication probability":1,
"tumor control probability":1,
"Antithyroglobulin antibody":1,
"surrogate marker":1,
"thyroid papillary carcinoma":1,
"RNA modification":1,
"TCGA":2,
"m6A":1,
"8th TNM edition":1,
"Depth of invasion":1,
"Nodal metastasis":1,
"Number of positive nodes":1,
"Oral cancer":1,
"Oral squamous cell carcinoma":1,
"Perineural invasion":1,
"BRAF V600E":1,
"TERT promoter mutations":1,
"total thyroidectomy":1,
"COVID-19":1,
"SARS-CoV-2":1,
"chest radiograph":1,
"moxifloxacin":1,
"procalcitonin":1,
"Gene expression":1,
"microRNA":1,
"molecular markers":1,
"Crizotinib":1,
"Hürthle cell tumors":1,
"Medicine":1,
"Oncocytic tumors of the thyroid":1,
"Precision":1,
"Bilateral breast cancer":1,
"Intraductal components":1,
"Metastatic breast lesion":1,
"carbon nanoparticles":1,
"rⅥb region lymph node":1,
"1H NMR&nbsp":1,
"spectroscopy":1,
"metabolomics":1,
"brain metastasis":1,
"dogs":1,
"renal interstitial cell tumor":1,
"renal neoplasia":1,
"ALDH5A1":1,
"EMT":1,
"invasion":1,
"5-FU, 5-fluorouracyl":1,
"ACVR2A, activin A receptor type 2A":1,
"AKT, AKT serine/threonine kinase":1,
"AR, androgen receptor":1,
"ATG7, autophagy related 7":1,
"ATM, ATM serine/threonine kinase":1,
"BAX, BCL2 associated Xapoptosis regulator":1,
"BCL2, BCL2 apoptosis regulator":1,
"BCL2L10, BCL2 like 10":1,
"BDNF, brain derived neurotrophic factor":1,
"BLCA, bladder urothelial carcinoma":1,
"BRCA, breast cancer":1,
"Biomarker":3,
"Bp, base pair":1,
"C-myc (MYCBP), MYC binding protein":1,
"CASC2, cancer susceptibility 2":1,
"CD133 (PROM1), prominin 1":1,
"CDC42, cell division cycle 42":1,
"CDKN1, Bcyclin dependent kinase inhibitor 1B":1,
"COAD, colon adenocarcinoma":1,
"Circulating miRNA":1,
"DDR, DNA damage repair":1,
"E2F family (E2F1, E2F2, E2F3), E2F transcription factors":1,
"EBV, Epstein-Barr virus":1,
"EMT, epithelial-to-mesenchymal transition":1,
"ER, estrogen receptor":1,
"ERBB (EGFR), epidermal growth factor receptor":1,
"ESCA, esophageal carcinoma":1,
"FENDRR, FOXF1 adjacent non-coding developmental regulatory RNA":1,
"FER1L4, fer-1 like family member 4 (pseudogene)":1,
"GAS5, growth arrest–specific 5":1,
"HIF-1α (HIF1A), hypoxia inducible factor 1 subunit alpha":1,
"HNRNPA1, heterogeneous nuclear ribonucleoprotein A1":1,
"HNSC, head and neck squamous cell carcinoma":1,
"HRR, homologous recombination-based DNA repair":1,
"IFN-γ (IFNG), interferon gamma":1,
"IGF1, insulin like growth factor 1":1,
"IL6, interleukin 6":1,
"IPMK, inositol phosphate multikinase":1,
"KIRC, clear cell kidney carcinoma":1,
"KIRP, kidney renal papillary cell carcinoma":1,
"KRAS, KRAS proto-oncogene, GTPase":1,
"LIHC, liver hepatocellular carcinoma":1,
"LMP1, latent membrane protein 1":1,
"LUAD, lung adenocarcinoma":1,
"LUSC, lung squamous cell carcinoma":1,
"Liquid biopsy":1,
"MAPK, mitogen-activated protein kinase":1,
"MCM7, minichromosome maintenance complex component 7":1,
"MET, mesenchymal-to-epithelial transition":1,
"MTOR, mechanistic target of rapamycin kinase":1,
"N-myc (MYCN), MYCN proto-oncogene, bHLH transcription factor":1,
"NF-κB, nuclear factor kappa-light-chain-enhancer of activated B cells":1,
"NOTCH2, notch receptor 2":1,
"Oncogene":1,
"PAAD, pancreatic adenocarcinoma":1,
"PERK (EIF2AK3), eukaryotic translation initiation factor 2 alpha kinase 3":1,
"PI3K (PIK3CA), phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha":1,
"PIAS3, protein inhibitor of activated STAT 3":1,
"PRAD, prostate adenocarcinoma":1,
"RISC, RNA-induced silencing complex":1,
"SMAD2, SMAD family member 2":1,
"SMG1, SMG1 nonsense mediated mRNA decay associated PI3K related kinase":1,
"SNHG1, small nucleolar RNA host gene 1":1,
"SOCS5, suppressor of cytokine signaling 5":1,
"STAD, stomach adenocarcinoma":1,
"STAT3, signal transducer and activator of transcription 3":1,
"STK4, serine/threonine kinase 4":1,
"Suppressor":1,
"TCGA, The Cancer Genome Atlas":1,
"TGF-β (TGFB1), transforming growth factor beta 1":1,
"TGFBR2, transforming growth factor beta receptor 2":1,
"THCA, papillary thyroid carcinoma":1,
"TNM, Classification of Malignant Tumors: T - tumor / N - lymph nodes / M – metastasis":1,
"TP53, tumor protein p53":1,
"TP53TG1, TP53 target 1":1,
"TRIAP1, p53-regulating inhibitor of apoptosis gene":1,
"TSC1, TSC complex subunit 1":1,
"UCA1, urothelial cancer associated 1":1,
"UCEC, uterine corpus endometrial carcinoma":1,
"UTR, untranslated region":1,
"WDFY3-AS2, WDFY3 antisense RNA 2":1,
"WEE1, WEE1 G2 checkpoint kinase":1,
"WNT family, Wingless-type MMTV integration site family/Wnt family ligands":1,
"ZEB1/ZEB2, zinc finger E-box binding homeobox 1 and 2":1,
"ceRNA, competitive endogenous RNA":1,
"cncRNA, protein coding and non-coding RNA":1,
"lncRNA, long-non coding RNA":1,
"miR-17-92a":1,
"miR-18a":1,
"Hamartoma syndrome, multiple":1,
"Neoplasms, second primary":1,
"Whole-exome sequencing":1,
"Helicase":1,
"WRN":1,
"Werner Syndrome Protein":1,
"central lymph node metastasis (CLNM)":1,
"prediction":1,
"LINC01134":1,
"Long noncoding RNA":1,
"SSRP1":1,
"miR‐4784":1,
"Extranodal non Hodgkin’s lymphoma":1,
"Primary thyroid lymphoma":1,
"Thyroid malignancy":1,
"ER stress":1,
"laryngeal carcinoma":1,
"oridonin":1,
"Minimally invasive":1,
"follicular carcinoma":1,
"widely invasive":1,
"Hypertensive crisis":1,
"Paraganglioma":1,
"SDHD gene":1,
"Metastatic cervical lymphadenopathy":1,
"ccRCC":1,
"miR-758-3p":1,
"comorbidity":1,
"essential thrombocythemia":1,
"myeloproliferative neoplasms":1,
"polycythemia vera":1,
"primary myelofibrosis":1,
"solid cancer":1,
"FT3":1,
"FT4":1,
"TSH":1,
"silencing mediator for retinoid and thyroid receptors":1,
"thyroid gland":1,
"Anaplastic thyroid carcinoma":1,
"lncRNAs":1,
"miRNAs":1,
"non-coding RNAs":1,
"siRNAs":1,
"PAX8/PPARγ":1,
"RAS":1,
"histiocytic sarcoma":1            };
            var data = [];
            for (var name in keywords) {
                data.push({
                    name: name,
                    value: Math.sqrt(keywords[name])
                })
            }
            var maskImage = new Image();
            var option = {
	             title: {
                text: '2020年4月论文keyword词云'
            },
                series: [ {
                    type: 'wordCloud',
                    sizeRange: [15, 100],
                    rotationRange: [-90, 90],
                    rotationStep: 45,
                    gridSize: 2,
                    shape: 'pentagon',
                    maskImage: maskImage,
                    drawOutOfBound: false,
                    textStyle: {
                        normal: {
                            color: function () {
                                return 'rgb(' + [
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160)
                                ].join(',') + ')';
                            }
                        },
                        emphasis: {
                            color: 'red'
                        }
                    },
                    data: data.sort(function (a, b) {
                        return b.value  - a.value;
                    })
                } ]
            };
            maskImage.onload = function () {
                option.series[0].maskImage
                chart.setOption(option);
            }
            maskImage.src = 'data:image/png;base64,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';
            window.onresize = function () {
                chart.resize();
            }
        </script>
    </body>
</html>
